P3 Research Ltd
Palmerston North, New Zealand
Research institute in Palmerston North
273 Broadway Avenue, Palmerston North Central, Palmerston North 4414
About P3 Research Ltd
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
BioNTech SE
1
Janssen Research & Development, LLC
1
Janssen Vaccines & Prevention B.V.
1
Novavax
1
Clinical Trials at P3 Research Ltd
During the past decade, P3 Research Ltd conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years
2021-06-30
2028-05-14
Recruiting
18,556
A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older
2021-07-21
2024-11-18
Recruiting
27,200
Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age
2022-04-20
2022-10-05
Completed
1,134
A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine
2022-12-30
2023-12-24
Active, not recruiting
1,579
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "P3 Research Ltd"
#1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at P3 Research Ltd
According to Clinical.Site data, the most researched conditions in "P3 Research Ltd" are
"COVID-19" (2 trials), "Influenza" (1 trials), "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials), "Lower Respiratory Tract Disease" (1 trials) and "Respiratory Syncytial Viruses" (1 trials). Many other conditions were trialed in "P3 Research Ltd" in a lesser frequency.
Clinical Trials Intervention Types at P3 Research Ltd
Most popular intervention types in "P3 Research Ltd" are "Biological" (3 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials), "BNT162b2" (1 trials), "CIC Vaccine" (1 trials) and "ExPEC9V" (1 trials). Other intervention names were less common.
Clinical Trials Genders at P3 Research Ltd
The vast majority of trials in "P3 Research Ltd" are
4 trials for "All" genders.
Clinical Trials Status at P3 Research Ltd
Currently, there are NaN active trials in "P3 Research Ltd".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in P3 Research Ltd,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in P3 Research Ltd, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".